LiPlaCis
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LiPlaCis, covering 2022-02-24 to 2022-02-24. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/II Study to Evaluate the Safety and Tolerability of LiPlaCis in Patients With Advanced or Refractory Tumours [Phase 1, Phase 2]